Gabriel Ganley, a 22-year-old bodybuilder and fitness influencer, was found dead in his São Paulo home on May 24, 2026 [1, 2].
His death has reignited a public and legislative debate in Brazil regarding the use of anabolic steroids and other performance-enhancing hormones. The case highlights the potential risks associated with unregulated substance use within the bodybuilding community and the influence of social media on fitness trends.
Ganley, known online as “BBzinho,” was a prominent figure in the fitness world [1, 2]. Investigations into his death suggest a link to the misuse of insulin and anabolic steroids, substances he had previously acknowledged using to increase muscle mass [1, 3, 4].
Medical reports on the cause of death vary among sources. Some reports suggest the misuse of insulin and anabolic steroids contributed to the fatality [1]. Other reports highlight hypertrophic cardiomyopathy, potentially aggravated by steroid use, as a key factor [4].
Ganley had publicly admitted to using anabolic steroids in 2023 [1]. This admission, combined with his sudden death, has prompted calls for tighter regulation of these substances to prevent similar tragedies among young athletes.
Legislators and health experts are now using the incident to address the perceived normalization of steroid use in the sport. The discussion centers on the lack of oversight and the dangers of self-administering potent hormones without medical supervision, a practice often glorified in fitness influencer circles [2, 5].
“Gabriel Ganley, a 22-year-old bodybuilder and fitness influencer, was found dead in his São Paulo home.”
The death of Gabriel Ganley underscores a growing tension between the aesthetic demands of professional bodybuilding and public health safety. By linking a high-profile influencer's death to the use of insulin and steroids, the event transforms a private medical tragedy into a policy catalyst, likely accelerating legislative efforts in Brazil to restrict the sale and distribution of performance-enhancing drugs.
